Hot on the heels of Facebook's historic initial public offering (IPO), musculoskeletal imaging firm EOS today announced the launch of its own IPO to trade its shares on the regulated NYSE Euronext Paris exchange.
The initial offer is for 30 million euros (4.8 million shares at a per-share price of 5.83 to 6.87), with an extension clause for a maximum 720,000 additional shares, the French-headquartered firm said in a statement.
The offer is set to conclude on 14 February, with shares to be priced on 15 February, negotiations with NYSE Euronext beginning 16 February, and settlement expected 20 February, the firm said.
